- Home
- QSI vs ANIK Comparison
QSI vs ANIK Comparison
Compare QSI & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QSI
- ANIK
- Stock Information
- Founded
- QSI 2013
- ANIK 1983
- Country
- QSI United States
- ANIK United States
- Employees
- QSI N/A
- ANIK N/A
- Industry
- QSI Biotechnology: Pharmaceutical Preparations
- ANIK Medical/Dental Instruments
- Sector
- QSI Health Care
- ANIK Health Care
- Exchange
- QSI Nasdaq
- ANIK Nasdaq
- Market Cap
- QSI 214.3M
- ANIK 196.6M
- IPO Year
- QSI N/A
- ANIK 1993
- Fundamental
- Price
- QSI $1.15
- ANIK $14.02
- Analyst Decision
- QSI Strong Buy
- ANIK Buy
- Analyst Count
- QSI 3
- ANIK 2
- Target Price
- QSI $3.42
- ANIK $22.00
- AVG Volume (30 Days)
- QSI 3.9M
- ANIK 77.6K
- Earning Date
- QSI 05-08-2025
- ANIK 05-07-2025
- Dividend Yield
- QSI N/A
- ANIK N/A
- EPS Growth
- QSI N/A
- ANIK N/A
- EPS
- QSI N/A
- ANIK N/A
- Revenue
- QSI $3,058,000.00
- ANIK $119,907,000.00
- Revenue This Year
- QSI $151.18
- ANIK N/A
- Revenue Next Year
- QSI $172.07
- ANIK $8.72
- P/E Ratio
- QSI N/A
- ANIK N/A
- Revenue Growth
- QSI 182.63
- ANIK N/A
- 52 Week Low
- QSI $0.61
- ANIK $12.83
- 52 Week High
- QSI $5.77
- ANIK $29.12
- Technical
- Relative Strength Index (RSI)
- QSI 40.89
- ANIK 41.05
- Support Level
- QSI $1.11
- ANIK $13.14
- Resistance Level
- QSI $1.31
- ANIK $14.32
- Average True Range (ATR)
- QSI 0.10
- ANIK 0.92
- MACD
- QSI 0.01
- ANIK 0.02
- Stochastic Oscillator
- QSI 45.61
- ANIK 45.42
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.